VistaGen Therapeutics, Inc. (VTGN)

NASDAQ: VTGN · IEX Real-Time Price · USD
5.28
+0.71 (15.54%)
Mar 28, 2024, 4:00 PM EDT - Market closed

VistaGen Therapeutics Market Cap

VistaGen Therapeutics has a market cap or net worth of $122.42 million as of March 28, 2024. Its market cap has increased by 317.83% in one year.

Market Cap
122.42M
Enterprise Value
-1.88M
1-Year Change
317.83%
Ranking
Category
Stock Price
$5.28

Market Cap Chart

Since May 11, 2016, VistaGen Therapeutics's market cap has increased from $9.30M to $122.42M, an increase of 1,216.39%. That is a compound annual growth rate of 38.68%.

History

DateMarket Cap% Change
Mar 27, 2024123.50M5.02%
Mar 26, 2024117.60M1.64%
Mar 25, 2024115.70M2.66%
Mar 22, 2024112.70M-1.05%
Mar 21, 2024113.90M1.06%
Mar 20, 2024112.70M0.45%
Mar 19, 2024112.20M2.28%
Mar 18, 2024109.70M0.18%
Mar 15, 2024109.50M3.40%
Mar 14, 2024105.90M-6.70%
Mar 13, 2024113.50M2.71%
Mar 12, 2024110.50M-1.95%
Mar 11, 2024112.70M-0.97%
Mar 8, 2024113.80M-0.61%
Mar 7, 2024114.50M-4.34%
Mar 6, 2024119.70M-1.32%
Mar 5, 2024121.30M-7.48%
Mar 4, 2024131.10M-4.31%
Mar 1, 2024137.00M-0.80%
Feb 29, 2024138.10M-1.92%
Feb 28, 2024140.80M-1.54%
Feb 27, 2024143.00M4.92%
Feb 26, 2024136.30M2.10%
Feb 23, 2024133.50M0.38%
Feb 22, 2024133.00M2.23%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Genetron Holdings 127.13M
Seer, Inc. 125.34M
Kinnate Biopharma 125.23M
The Oncology Institute 124.64M
Zentek 123.00M
Clearside Biomedical 119.55M
Seres Therapeutics 119.07M
Cardiol Therapeutics 118.51M
Market Cap Rankings